Luciferase Vsv Pseudotype

Lab Reagents

Human IgG antibody Laboratories manufactures the luciferase vsv pseudotype reagents distributed by Genprice. The Luciferase Vsv Pseudotype reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: Vsv Group: Pseudotype

Pseudotype information

VSV-g Tag Antibody

abx034631-400ul 400 ul
EUR 627.6

VSV-g Tag Antibody

abx034631-80l 80 µl
EUR 343.2

VSV- G tag Antibody

ABD2966 100 ug
EUR 525.6

VSV-G-Tag Antibody

20-abx242881
  • EUR 393.60
  • EUR 326.40
  • 100 ug
  • 50 ug

VSV-G Tag Antibody

RQ4681 100ul
EUR 419

VSV-G Tag Antibody (Biotin)

abx411894-50ug 50 ug
EUR 526.8

VSV-G-tag Conjugated Antibody

C48120 100ul
EUR 476.4

VSV-G-Tag Monoclonal Antibody

EM1005-100ul 100ul
EUR 334.8
Description: A Mouse Monoclonal antibody against VSV-G-Tag. This antibody is tested and validated for WB, ELISA

VSV-G-Tag Monoclonal Antibody

EM1005-50ul 50ul
EUR 248.4
Description: A Mouse Monoclonal antibody against VSV-G-Tag. This antibody is tested and validated for WB, ELISA

pCMV-VSV-G Retroviral Vector

RV-110 10 ?g
EUR 860.4
Description: Use this vector along with a packaging cell line and a cloning / expression vector for retroviral production.

Anti-VSV-G-Tag antibody

STJ96908 200 µl
EUR 236.4
Description: Mouse monoclonal to VSV-G-Tag.

Anti-VSV-G tag antibody

STJ140131 150 µg
EUR 489.6
Description: Goat polyclonal antibody to VSV-G epitope tag. VSV-G epitope tag is useful for the labelling and detection of proteins by immunoprecipitation, immunostaining and immunoblotting techniques. Because of its small size, it is unlikely to affect the tagged protein's biochemical properties.

Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)

78637-1 100 µl
EUR 795
Description: The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike corresponding to the initial strain (Genbank Accession #QHD43416.1) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6, Calu-3, and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G are preferred for use in cells such as Vero-E6 and Calu-3.The infectivity of VSV-Delta G pseudotypes is restricted to a single round of replication, therefore the pseudotypes can be handled using BSL-2 containment practices.

Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)

78637-2 500 µl x 2
EUR 3995
Description: The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike corresponding to the initial strain (Genbank Accession #QHD43416.1) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6, Calu-3, and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G are preferred for use in cells such as Vero-E6 and Calu-3.The infectivity of VSV-Delta G pseudotypes is restricted to a single round of replication, therefore the pseudotypes can be handled using BSL-2 containment practices.

Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)

78642-1 100 µl
EUR 795
Description: The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1; with D614G mutation) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 D614G variant in a Biosafety Level 2 facility.The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6 and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G is preferred over lentiviral-based spike pseudoviruses for use in cells such as Vero-E6 parental cells.

Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter)

78642-2 500 µl x 2
EUR 3995
Description: The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1; with D614G mutation) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 D614G variant in a Biosafety Level 2 facility.The Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6 and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G is preferred over lentiviral-based spike pseudoviruses for use in cells such as Vero-E6 parental cells.

VSV-G -Tag Mouse Monoclonal Antibody

T606-100ul 100ul
EUR 302.4